256 related articles for article (PubMed ID: 25791806)
1. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.
van der Valk FM; van Wijk DF; Lobatto ME; Verberne HJ; Storm G; Willems MC; Legemate DA; Nederveen AJ; Calcagno C; Mani V; Ramachandran S; Paridaans MP; Otten MJ; Dallinga-Thie GM; Fayad ZA; Nieuwdorp M; Schulte DM; Metselaar JM; Mulder WJ; Stroes ES
Nanomedicine; 2015 Jul; 11(5):1039-46. PubMed ID: 25791806
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy.
Lobatto ME; Calcagno C; Otten MJ; Millon A; Ramachandran S; Paridaans MP; van der Valk FM; Storm G; Stroes ES; Fayad ZA; Mulder WJ; Metselaar JM
Nanomedicine; 2015 Jul; 11(5):1133-40. PubMed ID: 25791805
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
Kluza E; Yeo SY; Schmid S; van der Schaft DW; Boekhoven RW; Schiffelers RM; Storm G; Strijkers GJ; Nicolay K
J Control Release; 2011 Apr; 151(1):10-7. PubMed ID: 21130819
[TBL] [Abstract][Full Text] [Related]
4. Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis.
van der Valk FM; Schulte DM; Meiler S; Tang J; Zheng KH; Van den Bossche J; Seijkens T; Laudes M; de Winther M; Lutgens E; Alaarg A; Metselaar JM; Dallinga-Thie GM; Mulder WJ; Stroes ES; Hamers AA
Nanomedicine; 2016 Aug; 12(6):1463-70. PubMed ID: 27015770
[TBL] [Abstract][Full Text] [Related]
5. Injectable liposomal docosahexaenoic acid alleviates atherosclerosis progression and enhances plaque stability.
Chong SY; Wang X; van Bloois L; Huang C; Syeda NS; Zhang S; Ting HJ; Nair V; Lin Y; Lou CKL; Benetti AA; Yu X; Lim NJY; Tan MS; Lim HY; Lim SY; Thiam CH; Looi WD; Zharkova O; Chew NWS; Ng CH; Bonney GK; Muthiah M; Chen X; Pastorin G; Richards AM; Angeli V; Storm G; Wang JW
J Control Release; 2023 Aug; 360():344-364. PubMed ID: 37406819
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat.
van Alem CMA; Boonstra M; Prins J; Bezhaeva T; van Essen MF; Ruben JM; Vahrmeijer AL; van der Veer EP; de Fijter JW; Reinders ME; Meijer O; Metselaar JM; van Kooten C; Rotmans JI
Nephrol Dial Transplant; 2018 Jan; 33(1):44-53. PubMed ID: 28992069
[TBL] [Abstract][Full Text] [Related]
7. An apoptotic body-biomimic liposome in situ upregulates anti-inflammatory macrophages for stabilization of atherosclerotic plaques.
Wu Y; Zhang Y; Dai L; Wang Q; Xue L; Su Z; Zhang C
J Control Release; 2019 Dec; 316():236-249. PubMed ID: 31672624
[TBL] [Abstract][Full Text] [Related]
8. Multiple pathway assessment to predict anti-atherogenic efficacy of drugs targeting macrophages in atherosclerotic plaques.
Alaarg A; Zheng KH; van der Valk FM; da Silva AE; Versloot M; van Ufford LC; Schulte DM; Storm G; Metselaar JM; Stroes ES; Hamers AA
Vascul Pharmacol; 2016 Jul; 82():51-9. PubMed ID: 27189780
[TBL] [Abstract][Full Text] [Related]
9. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.
Metselaar JM; Wauben MH; Wagenaar-Hilbers JP; Boerman OC; Storm G
Arthritis Rheum; 2003 Jul; 48(7):2059-66. PubMed ID: 12847701
[TBL] [Abstract][Full Text] [Related]
10. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
Joner M; Morimoto K; Kasukawa H; Steigerwald K; Merl S; Nakazawa G; John MC; Finn AV; Acampado E; Kolodgie FD; Gold HK; Virmani R
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1960-6. PubMed ID: 18688017
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.
Beldman TJ; Senders ML; Alaarg A; Pérez-Medina C; Tang J; Zhao Y; Fay F; Deichmöller J; Born B; Desclos E; van der Wel NN; Hoebe RA; Kohen F; Kartvelishvily E; Neeman M; Reiner T; Calcagno C; Fayad ZA; de Winther MPJ; Lutgens E; Mulder WJM; Kluza E
ACS Nano; 2017 Jun; 11(6):5785-5799. PubMed ID: 28463501
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies to deplete macrophages in atherosclerotic plaques.
De Meyer I; Martinet W; De Meyer GR
Br J Clin Pharmacol; 2012 Aug; 74(2):246-63. PubMed ID: 22309283
[TBL] [Abstract][Full Text] [Related]
13. Liposomal Nanotherapy for Treatment of Atherosclerosis.
Darwitan A; Wong YS; Nguyen LTH; Czarny B; Vincent A; Nedumaran AM; Tan YF; Muktabar A; Tang JK; Ng KW; Venkatraman S
Adv Healthc Mater; 2020 Jul; 9(14):e2000465. PubMed ID: 32543010
[TBL] [Abstract][Full Text] [Related]
14. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis.
Metselaar JM; van den Berg WB; Holthuysen AE; Wauben MH; Storm G; van Lent PL
Ann Rheum Dis; 2004 Apr; 63(4):348-53. PubMed ID: 15020326
[TBL] [Abstract][Full Text] [Related]
15. Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.
Lobatto ME; Fayad ZA; Silvera S; Vucic E; Calcagno C; Mani V; Dickson SD; Nicolay K; Banciu M; Schiffelers RM; Metselaar JM; van Bloois L; Wu HS; Fallon JT; Rudd JH; Fuster V; Fisher EA; Storm G; Mulder WJ
Mol Pharm; 2010 Dec; 7(6):2020-9. PubMed ID: 21028895
[TBL] [Abstract][Full Text] [Related]
16. Two Types of Liposomal Formulations Improve the Therapeutic Ratio of Prednisolone Phosphate in a Zebrafish Model for Inflammation.
Xie Y; Papadopoulou P; de Wit B; d'Engelbronner JC; van Hage P; Kros A; Schaaf MJM
Cells; 2022 Feb; 11(4):. PubMed ID: 35203318
[TBL] [Abstract][Full Text] [Related]
17. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis.
Chen W; Schilperoort M; Cao Y; Shi J; Tabas I; Tao W
Nat Rev Cardiol; 2022 Apr; 19(4):228-249. PubMed ID: 34759324
[TBL] [Abstract][Full Text] [Related]
18. Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide.
Hofkens W; van den Hoven JM; Pesman GJ; Nabbe KC; Sweep FC; Storm G; van den Berg WB; van Lent PL
Int J Pharm; 2011 Sep; 416(2):493-8. PubMed ID: 21382459
[TBL] [Abstract][Full Text] [Related]
19. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
20. [(18)]F FDG PET/CT imaging to monitor the therapeutic effect of liposome-encapsulated prednisolone in experimental rheumatoid arthritis.
van der Geest T; Metselaar JM; Gerrits D; van Lent PL; Storm G; Laverman P; Boerman OC
J Control Release; 2015 Jul; 209():20-6. PubMed ID: 25902038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
